Barts Cancer Institute (BCI) at Queen Mary University of London, is a leading UK cancer research institute, and key partner in the Cancer Research UK City of London Centre.

Under the leadership of the Director, Professor Nick Lemoine, and supported by an Executive Board of senior investigators, we have created an academic environment fitting for an internationally recognised, comprehensive cancer centre. BCI, as part of the Barts and The London School of Medicine and Dentistry, is in the top 10 multi-faculty research institutions (REF 2014).

Our staff and students focus their efforts on two objectives; how to increase the chances of survival through early detection and diagnosis; and improving patient survival through the discovery and development of more effective and innovative therapies. These objectives are underpinned by research into improving our understanding of the basic cell and molecular biology of cancer and the body’s natural immune response to it.

We also use our expertise to teach and educate students and professionals about the science of and gold-standard clinical approaches to cancer, and to engage our local population.

We hope to make the often difficult subject of cancer accessible to anyone that requires or is interested in our research.

Barts Cancer Institute

Similar companies